CClinicalTrials.gg
CompletedNCT01557686PACE-ALUpdated Mar 19, 2012

Health Counseling and Exercise in Patients With Acute Leukemia - Pilot Study

An Early Phase 1 interventional study of Health counseling and exercise in Acute Leukemia, sponsored by Universitetshospitalernes Center for Sygepleje. Completed at 2 sites in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-03-19.

Sponsored by Universitetshospitalernes Center for Sygepleje · Early Phase 1, Interventional, and Supportive care

Phase
Early Phase 1
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this pilot study is to test an exercise-based multidimensional intervention for patients with acute leukaemia undergoing consolidation chemotherapy in the context of outpatient management. Further, to test for safety, feasibility and preliminary effect on physical and functional capacity, and health related quality of life.

02

Conditions studied

  • Acute Leukemia

Keywords

  • Cancer Related fatigue
  • Quality of Life
  • Psychosocial Intervention
  • Rehabilitation
  • Physical Fitness
  • Physical Activity
  • Exercise Therapy
  • Exercise
  • Hematologic
  • Hematological
  • Leukemia, Myeloid, Acute
  • Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Acute Leukemia
03

In context

Leukemia

5,441 studies on the registry are indexed under Leukemia; 636 are open to participants now.

This study's enrollment of 20 is below the median of 38 across 4,247 interventional studies indexed under Leukemia.

Browse Leukemia studies →

Lead sponsor

Universitetshospitalernes Center for Sygepleje is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients that are able to speak Danish > 18 years and newly diagnosed with acute leukæmia (MDS, AML, CMML, APL or ALL)
  • Normal EKG, blood pressure and pulse
  • Signed informed written consent

Exclusion criteria

Exclusion Criteria:

  • Medical reason that contraindicates physical activity
  • Patients diagnosed with a symptomatic cardiac disease within the last three months.
  • Documented bone metastasis
  • Dementia, psychotic
  • Cannot write or read Danish
  • Patients unable to carry out baseline tests
05

Study design

Phase
Early Phase 1
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (actual)

Interventions

  • BehavioralHealth counseling and exercise

    The intervention is initiated during chemotherapy treatment (consolidation) in the outpatient clinic and continues for 6 weeks. The intervention is a three hour/wk supervised in-hospital programme of aerobic (stationary cycle) and functional muscle training, progressive relaxation training, nutrition supplement (protein and carbohydrate) immediately after training and two health-promoting counseling sessions - Further, patients are fitted with a step counter pedometer.

06

What researchers measure

Primary outcomes

  1. Feasibility - adherence rates

    Percentage of intervention participation

    Time frame: Adherence to the intervention components from baseline to 6 weeks

Secondary outcomes

  1. Adverse events

    Number and type of adverse events

    Time frame: baseline to 6 weeks

  2. 6MWD

    Change in distance in meter

    Time frame: Change from baseline in 6MWD at 6 weeks

  3. Attrition

    Number of patients that withdrew from the project

    Time frame: Withdrawal from the project from baseline to 6 weeks

  4. Timed chair stand

    Change in the number of repetitions

    Time frame: Change from baseline in timed chair stand at 6 weeks

  5. Timed bicep curl

    Change in number of repetitions

    Time frame: Change from baseline in timed bicep curl at 6 weeks

  6. FACT-Anemia

    Change in scores for quality of life/function

    Time frame: Change from baseline in FACT-An at 6 weeks

  7. HADS

    Change in scores for emotional wellbeing

    Time frame: Change from baseline in HADS at 6 weeks

  8. SF36

    Change in scores for general health

    Time frame: Change from baseline in SF36 at 6 weeks

  9. MDSAI

    Change in scores for symptom burden

    Time frame: Change from baseline over time (1,2,3,4,5,6 weeks)

07

Study locations

2 sites
  • Copenhagen University Hospital
    Copenhagen, Denmark
  • Herlev Hospital
    Herlev, Denmark
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 19, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01557686
Lead sponsor
Universitetshospitalernes Center for Sygepleje
Collaborators
Novo Nordisk A/S, Lundbeck Foundation
Responsible party
Mary Jarden (Research Fellow, Universitetshospitalernes Center for Sygepleje) — Principal investigator
First posted
Mar 19, 2012
Start date
May 2010
Primary completion
Feb 2011
Completion
Feb 2011
Last update
Mar 19, 2012

Study contacts

Mary Jarden, Ph.D.
principal investigator · Copenhagen University Hospital at Herlev

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion